{"id":"https://openalex.org/W2802197205","doi":"https://doi.org/10.1097/md.0000000000010449","title":"Phase I study of cord blood transplantation with intrabone marrow injection of mesenchymal stem cells","display_name":"Phase I study of cord blood transplantation with intrabone marrow injection of mesenchymal stem cells","publication_year":2018,"publication_date":"2018-04-01","ids":{"openalex":"https://openalex.org/W2802197205","doi":"https://doi.org/10.1097/md.0000000000010449","mag":"2802197205","pmid":"https://pubmed.ncbi.nlm.nih.gov/29702996","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/5944542"},"language":"en","primary_location":{"id":"doi:10.1097/md.0000000000010449","doi":"https://doi.org/10.1097/md.0000000000010449","is_oa":true,"landing_page_url":"https://doi.org/10.1097/md.0000000000010449","pdf_url":null,"source":{"id":"https://openalex.org/S28966261","display_name":"Medicine","issn_l":"0025-7974","issn":["0025-7974","1536-5964"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Medicine","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1097/md.0000000000010449","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5019313553","display_name":"Tatsunori Goto","orcid":"https://orcid.org/0000-0002-0314-9498","observed_orcids":["https://orcid.org/0000-0002-0314-9498"]},"institutions":[{"id":"https://openalex.org/I1333985979","display_name":"Ministry of Health Labour and Welfare","ror":"https://ror.org/03mwa7s65","country_code":"JP","type":"government","lineage":["https://openalex.org/I1333985979"]},{"id":"https://openalex.org/I205823427","display_name":"Kyowa Kirin (Japan)","ror":"https://ror.org/000wej815","country_code":"JP","type":"company","lineage":["https://openalex.org/I205823427"]},{"id":"https://openalex.org/I60134161","display_name":"Nagoya University","ror":"https://ror.org/04chrp450","country_code":"JP","type":"education","lineage":["https://openalex.org/I60134161"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tatsunori Goto","raw_affiliation_strings":["Department of Hematology and Oncology, Nagoya University Graduate School of Medicine","Authorship: TG and MM devised the research and drafted this manuscript. ST, TN, YA, YU, KS, YI, FH, NN, SN, AH, KK, YT, and HK gave advice regarding the study design and data collection. All authors read and approved the final manuscript","Conflict of interest: HK received research funding from Kyowa Hakko Kirin Co., Ltd, Otsuka Pharmaceutical Co., Ltd, FUJIFILM Corporation, Nippon Boehringer Ingelheim Co., Ltd, and Celgene Corporation. These companies are not directly involved in any part of this study. The remaining authors have declared there are no financial conflicts of interest with regard to this study","Ethics and dissemination: The compliance of this study with the Act on the Safety of Regenerative Medicine was confirmed by the Ministry of Health, Labour and Welfare of Japan (number PA8160004). Written informed consent will be obtained from all patients and donors before registration, in accordance with the Declaration of Helsinki. Results of this study will be disseminated via publications in peer-reviewed journals","Trial registration: Trial registration number UMIN000024291"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology and Oncology, Nagoya University Graduate School of Medicine","institution_ids":["https://openalex.org/I60134161"]},{"raw_affiliation_string":"Authorship: TG and MM devised the research and drafted this manuscript. ST, TN, YA, YU, KS, YI, FH, NN, SN, AH, KK, YT, and HK gave advice regarding the study design and data collection. All authors read and approved the final manuscript","institution_ids":[]},{"raw_affiliation_string":"Conflict of interest: HK received research funding from Kyowa Hakko Kirin Co., Ltd, Otsuka Pharmaceutical Co., Ltd, FUJIFILM Corporation, Nippon Boehringer Ingelheim Co., Ltd, and Celgene Corporation. These companies are not directly involved in any part of this study. The remaining authors have declared there are no financial conflicts of interest with regard to this study","institution_ids":["https://openalex.org/I205823427"]},{"raw_affiliation_string":"Ethics and dissemination: The compliance of this study with the Act on the Safety of Regenerative Medicine was confirmed by the Ministry of Health, Labour and Welfare of Japan (number PA8160004). Written informed consent will be obtained from all patients and donors before registration, in accordance with the Declaration of Helsinki. Results of this study will be disseminated via publications in peer-reviewed journals","institution_ids":["https://openalex.org/I1333985979"]},{"raw_affiliation_string":"Trial registration: Trial registration number UMIN000024291","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022043062","display_name":"Makoto Murata","orcid":"https://orcid.org/0000-0001-5488-4364","observed_orcids":["https://orcid.org/0000-0001-5488-4364"]},"institutions":[{"id":"https://openalex.org/I60134161","display_name":"Nagoya University","ror":"https://ror.org/04chrp450","country_code":"JP","type":"education","lineage":["https://openalex.org/I60134161"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Makoto Murata","raw_affiliation_strings":["Department of Hematology and Oncology, Nagoya University Graduate School of Medicine","Makoto Murata, Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, 65 Tsurumai, Showa, Nagoya, Aichi 466-8550, Japan (e-mail: [email\u00a0protected])"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology and Oncology, Nagoya University Graduate School of Medicine","institution_ids":["https://openalex.org/I60134161"]},{"raw_affiliation_string":"Makoto Murata, Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, 65 Tsurumai, Showa, Nagoya, Aichi 466-8550, Japan (e-mail: [email\u00a0protected])","institution_ids":["https://openalex.org/I60134161"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024388913","display_name":"Seitaro Terakura","orcid":"https://orcid.org/0000-0002-1194-8046","observed_orcids":["https://orcid.org/0000-0002-1194-8046"]},"institutions":[{"id":"https://openalex.org/I1333985979","display_name":"Ministry of Health Labour and Welfare","ror":"https://ror.org/03mwa7s65","country_code":"JP","type":"government","lineage":["https://openalex.org/I1333985979"]},{"id":"https://openalex.org/I205823427","display_name":"Kyowa Kirin (Japan)","ror":"https://ror.org/000wej815","country_code":"JP","type":"company","lineage":["https://openalex.org/I205823427"]},{"id":"https://openalex.org/I60134161","display_name":"Nagoya University","ror":"https://ror.org/04chrp450","country_code":"JP","type":"education","lineage":["https://openalex.org/I60134161"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Seitaro Terakura","raw_affiliation_strings":["Department of Hematology and Oncology, Nagoya University Graduate School of Medicine","Authorship: TG and MM devised the research and drafted this manuscript. ST, TN, YA, YU, KS, YI, FH, NN, SN, AH, KK, YT, and HK gave advice regarding the study design and data collection. All authors read and approved the final manuscript","Conflict of interest: HK received research funding from Kyowa Hakko Kirin Co., Ltd, Otsuka Pharmaceutical Co., Ltd, FUJIFILM Corporation, Nippon Boehringer Ingelheim Co., Ltd, and Celgene Corporation. These companies are not directly involved in any part of this study. The remaining authors have declared there are no financial conflicts of interest with regard to this study","Ethics and dissemination: The compliance of this study with the Act on the Safety of Regenerative Medicine was confirmed by the Ministry of Health, Labour and Welfare of Japan (number PA8160004). Written informed consent will be obtained from all patients and donors before registration, in accordance with the Declaration of Helsinki. Results of this study will be disseminated via publications in peer-reviewed journals","Trial registration: Trial registration number UMIN000024291"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology and Oncology, Nagoya University Graduate School of Medicine","institution_ids":["https://openalex.org/I60134161"]},{"raw_affiliation_string":"Authorship: TG and MM devised the research and drafted this manuscript. ST, TN, YA, YU, KS, YI, FH, NN, SN, AH, KK, YT, and HK gave advice regarding the study design and data collection. All authors read and approved the final manuscript","institution_ids":[]},{"raw_affiliation_string":"Conflict of interest: HK received research funding from Kyowa Hakko Kirin Co., Ltd, Otsuka Pharmaceutical Co., Ltd, FUJIFILM Corporation, Nippon Boehringer Ingelheim Co., Ltd, and Celgene Corporation. These companies are not directly involved in any part of this study. The remaining authors have declared there are no financial conflicts of interest with regard to this study","institution_ids":["https://openalex.org/I205823427"]},{"raw_affiliation_string":"Ethics and dissemination: The compliance of this study with the Act on the Safety of Regenerative Medicine was confirmed by the Ministry of Health, Labour and Welfare of Japan (number PA8160004). Written informed consent will be obtained from all patients and donors before registration, in accordance with the Declaration of Helsinki. Results of this study will be disseminated via publications in peer-reviewed journals","institution_ids":["https://openalex.org/I1333985979"]},{"raw_affiliation_string":"Trial registration: Trial registration number UMIN000024291","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044987926","display_name":"Tetsuya Nishida","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1333985979","display_name":"Ministry of Health Labour and Welfare","ror":"https://ror.org/03mwa7s65","country_code":"JP","type":"government","lineage":["https://openalex.org/I1333985979"]},{"id":"https://openalex.org/I205823427","display_name":"Kyowa Kirin (Japan)","ror":"https://ror.org/000wej815","country_code":"JP","type":"company","lineage":["https://openalex.org/I205823427"]},{"id":"https://openalex.org/I60134161","display_name":"Nagoya University","ror":"https://ror.org/04chrp450","country_code":"JP","type":"education","lineage":["https://openalex.org/I60134161"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tetsuya Nishida","raw_affiliation_strings":["Department of Hematology and Oncology, Nagoya University Graduate School of Medicine","Authorship: TG and MM devised the research and drafted this manuscript. ST, TN, YA, YU, KS, YI, FH, NN, SN, AH, KK, YT, and HK gave advice regarding the study design and data collection. All authors read and approved the final manuscript","Conflict of interest: HK received research funding from Kyowa Hakko Kirin Co., Ltd, Otsuka Pharmaceutical Co., Ltd, FUJIFILM Corporation, Nippon Boehringer Ingelheim Co., Ltd, and Celgene Corporation. These companies are not directly involved in any part of this study. The remaining authors have declared there are no financial conflicts of interest with regard to this study","Ethics and dissemination: The compliance of this study with the Act on the Safety of Regenerative Medicine was confirmed by the Ministry of Health, Labour and Welfare of Japan (number PA8160004). Written informed consent will be obtained from all patients and donors before registration, in accordance with the Declaration of Helsinki. Results of this study will be disseminated via publications in peer-reviewed journals","Trial registration: Trial registration number UMIN000024291"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology and Oncology, Nagoya University Graduate School of Medicine","institution_ids":["https://openalex.org/I60134161"]},{"raw_affiliation_string":"Authorship: TG and MM devised the research and drafted this manuscript. ST, TN, YA, YU, KS, YI, FH, NN, SN, AH, KK, YT, and HK gave advice regarding the study design and data collection. All authors read and approved the final manuscript","institution_ids":[]},{"raw_affiliation_string":"Conflict of interest: HK received research funding from Kyowa Hakko Kirin Co., Ltd, Otsuka Pharmaceutical Co., Ltd, FUJIFILM Corporation, Nippon Boehringer Ingelheim Co., Ltd, and Celgene Corporation. These companies are not directly involved in any part of this study. The remaining authors have declared there are no financial conflicts of interest with regard to this study","institution_ids":["https://openalex.org/I205823427"]},{"raw_affiliation_string":"Ethics and dissemination: The compliance of this study with the Act on the Safety of Regenerative Medicine was confirmed by the Ministry of Health, Labour and Welfare of Japan (number PA8160004). Written informed consent will be obtained from all patients and donors before registration, in accordance with the Declaration of Helsinki. Results of this study will be disseminated via publications in peer-reviewed journals","institution_ids":["https://openalex.org/I1333985979"]},{"raw_affiliation_string":"Trial registration: Trial registration number UMIN000024291","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102968802","display_name":"Yoshiya Adachi","orcid":"https://orcid.org/0000-0002-8321-0390","observed_orcids":["https://orcid.org/0000-0002-8321-0390"]},"institutions":[{"id":"https://openalex.org/I1333985979","display_name":"Ministry of Health Labour and Welfare","ror":"https://ror.org/03mwa7s65","country_code":"JP","type":"government","lineage":["https://openalex.org/I1333985979"]},{"id":"https://openalex.org/I205823427","display_name":"Kyowa Kirin (Japan)","ror":"https://ror.org/000wej815","country_code":"JP","type":"company","lineage":["https://openalex.org/I205823427"]},{"id":"https://openalex.org/I60134161","display_name":"Nagoya University","ror":"https://ror.org/04chrp450","country_code":"JP","type":"education","lineage":["https://openalex.org/I60134161"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yoshiya Adachi","raw_affiliation_strings":["Department of Hematology and Oncology, Nagoya University Graduate School of Medicine","Authorship: TG and MM devised the research and drafted this manuscript. ST, TN, YA, YU, KS, YI, FH, NN, SN, AH, KK, YT, and HK gave advice regarding the study design and data collection. All authors read and approved the final manuscript","Conflict of interest: HK received research funding from Kyowa Hakko Kirin Co., Ltd, Otsuka Pharmaceutical Co., Ltd, FUJIFILM Corporation, Nippon Boehringer Ingelheim Co., Ltd, and Celgene Corporation. These companies are not directly involved in any part of this study. The remaining authors have declared there are no financial conflicts of interest with regard to this study","Ethics and dissemination: The compliance of this study with the Act on the Safety of Regenerative Medicine was confirmed by the Ministry of Health, Labour and Welfare of Japan (number PA8160004). Written informed consent will be obtained from all patients and donors before registration, in accordance with the Declaration of Helsinki. Results of this study will be disseminated via publications in peer-reviewed journals","Trial registration: Trial registration number UMIN000024291"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology and Oncology, Nagoya University Graduate School of Medicine","institution_ids":["https://openalex.org/I60134161"]},{"raw_affiliation_string":"Authorship: TG and MM devised the research and drafted this manuscript. ST, TN, YA, YU, KS, YI, FH, NN, SN, AH, KK, YT, and HK gave advice regarding the study design and data collection. All authors read and approved the final manuscript","institution_ids":[]},{"raw_affiliation_string":"Conflict of interest: HK received research funding from Kyowa Hakko Kirin Co., Ltd, Otsuka Pharmaceutical Co., Ltd, FUJIFILM Corporation, Nippon Boehringer Ingelheim Co., Ltd, and Celgene Corporation. These companies are not directly involved in any part of this study. The remaining authors have declared there are no financial conflicts of interest with regard to this study","institution_ids":["https://openalex.org/I205823427"]},{"raw_affiliation_string":"Ethics and dissemination: The compliance of this study with the Act on the Safety of Regenerative Medicine was confirmed by the Ministry of Health, Labour and Welfare of Japan (number PA8160004). Written informed consent will be obtained from all patients and donors before registration, in accordance with the Declaration of Helsinki. Results of this study will be disseminated via publications in peer-reviewed journals","institution_ids":["https://openalex.org/I1333985979"]},{"raw_affiliation_string":"Trial registration: Trial registration number UMIN000024291","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044048807","display_name":"Yoko Ushijima","orcid":"https://orcid.org/0000-0002-2897-2843","observed_orcids":["https://orcid.org/0000-0002-2897-2843"]},"institutions":[{"id":"https://openalex.org/I1333985979","display_name":"Ministry of Health Labour and Welfare","ror":"https://ror.org/03mwa7s65","country_code":"JP","type":"government","lineage":["https://openalex.org/I1333985979"]},{"id":"https://openalex.org/I205823427","display_name":"Kyowa Kirin (Japan)","ror":"https://ror.org/000wej815","country_code":"JP","type":"company","lineage":["https://openalex.org/I205823427"]},{"id":"https://openalex.org/I60134161","display_name":"Nagoya University","ror":"https://ror.org/04chrp450","country_code":"JP","type":"education","lineage":["https://openalex.org/I60134161"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yoko Ushijima","raw_affiliation_strings":["Department of Hematology and Oncology, Nagoya University Graduate School of Medicine","Authorship: TG and MM devised the research and drafted this manuscript. ST, TN, YA, YU, KS, YI, FH, NN, SN, AH, KK, YT, and HK gave advice regarding the study design and data collection. All authors read and approved the final manuscript","Conflict of interest: HK received research funding from Kyowa Hakko Kirin Co., Ltd, Otsuka Pharmaceutical Co., Ltd, FUJIFILM Corporation, Nippon Boehringer Ingelheim Co., Ltd, and Celgene Corporation. These companies are not directly involved in any part of this study. The remaining authors have declared there are no financial conflicts of interest with regard to this study","Ethics and dissemination: The compliance of this study with the Act on the Safety of Regenerative Medicine was confirmed by the Ministry of Health, Labour and Welfare of Japan (number PA8160004). Written informed consent will be obtained from all patients and donors before registration, in accordance with the Declaration of Helsinki. Results of this study will be disseminated via publications in peer-reviewed journals","Trial registration: Trial registration number UMIN000024291"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology and Oncology, Nagoya University Graduate School of Medicine","institution_ids":["https://openalex.org/I60134161"]},{"raw_affiliation_string":"Authorship: TG and MM devised the research and drafted this manuscript. ST, TN, YA, YU, KS, YI, FH, NN, SN, AH, KK, YT, and HK gave advice regarding the study design and data collection. All authors read and approved the final manuscript","institution_ids":[]},{"raw_affiliation_string":"Conflict of interest: HK received research funding from Kyowa Hakko Kirin Co., Ltd, Otsuka Pharmaceutical Co., Ltd, FUJIFILM Corporation, Nippon Boehringer Ingelheim Co., Ltd, and Celgene Corporation. These companies are not directly involved in any part of this study. The remaining authors have declared there are no financial conflicts of interest with regard to this study","institution_ids":["https://openalex.org/I205823427"]},{"raw_affiliation_string":"Ethics and dissemination: The compliance of this study with the Act on the Safety of Regenerative Medicine was confirmed by the Ministry of Health, Labour and Welfare of Japan (number PA8160004). Written informed consent will be obtained from all patients and donors before registration, in accordance with the Declaration of Helsinki. Results of this study will be disseminated via publications in peer-reviewed journals","institution_ids":["https://openalex.org/I1333985979"]},{"raw_affiliation_string":"Trial registration: Trial registration number UMIN000024291","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068557516","display_name":"Kazuyuki Shimada","orcid":"https://orcid.org/0000-0002-1075-9219","observed_orcids":["https://orcid.org/0000-0002-1075-9219"]},"institutions":[{"id":"https://openalex.org/I1333985979","display_name":"Ministry of Health Labour and Welfare","ror":"https://ror.org/03mwa7s65","country_code":"JP","type":"government","lineage":["https://openalex.org/I1333985979"]},{"id":"https://openalex.org/I205823427","display_name":"Kyowa Kirin (Japan)","ror":"https://ror.org/000wej815","country_code":"JP","type":"company","lineage":["https://openalex.org/I205823427"]},{"id":"https://openalex.org/I60134161","display_name":"Nagoya University","ror":"https://ror.org/04chrp450","country_code":"JP","type":"education","lineage":["https://openalex.org/I60134161"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kazuyuki Shimada","raw_affiliation_strings":["Department of Hematology and Oncology, Nagoya University Graduate School of Medicine","Authorship: TG and MM devised the research and drafted this manuscript. ST, TN, YA, YU, KS, YI, FH, NN, SN, AH, KK, YT, and HK gave advice regarding the study design and data collection. All authors read and approved the final manuscript","Conflict of interest: HK received research funding from Kyowa Hakko Kirin Co., Ltd, Otsuka Pharmaceutical Co., Ltd, FUJIFILM Corporation, Nippon Boehringer Ingelheim Co., Ltd, and Celgene Corporation. These companies are not directly involved in any part of this study. The remaining authors have declared there are no financial conflicts of interest with regard to this study","Ethics and dissemination: The compliance of this study with the Act on the Safety of Regenerative Medicine was confirmed by the Ministry of Health, Labour and Welfare of Japan (number PA8160004). Written informed consent will be obtained from all patients and donors before registration, in accordance with the Declaration of Helsinki. Results of this study will be disseminated via publications in peer-reviewed journals","Trial registration: Trial registration number UMIN000024291"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology and Oncology, Nagoya University Graduate School of Medicine","institution_ids":["https://openalex.org/I60134161"]},{"raw_affiliation_string":"Authorship: TG and MM devised the research and drafted this manuscript. ST, TN, YA, YU, KS, YI, FH, NN, SN, AH, KK, YT, and HK gave advice regarding the study design and data collection. All authors read and approved the final manuscript","institution_ids":[]},{"raw_affiliation_string":"Conflict of interest: HK received research funding from Kyowa Hakko Kirin Co., Ltd, Otsuka Pharmaceutical Co., Ltd, FUJIFILM Corporation, Nippon Boehringer Ingelheim Co., Ltd, and Celgene Corporation. These companies are not directly involved in any part of this study. The remaining authors have declared there are no financial conflicts of interest with regard to this study","institution_ids":["https://openalex.org/I205823427"]},{"raw_affiliation_string":"Ethics and dissemination: The compliance of this study with the Act on the Safety of Regenerative Medicine was confirmed by the Ministry of Health, Labour and Welfare of Japan (number PA8160004). Written informed consent will be obtained from all patients and donors before registration, in accordance with the Declaration of Helsinki. Results of this study will be disseminated via publications in peer-reviewed journals","institution_ids":["https://openalex.org/I1333985979"]},{"raw_affiliation_string":"Trial registration: Trial registration number UMIN000024291","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036422444","display_name":"Yuichi Ishikawa","orcid":"https://orcid.org/0000-0001-6024-6617","observed_orcids":["https://orcid.org/0000-0001-6024-6617","https://orcid.org/0000-0001-7926-5869"]},"institutions":[{"id":"https://openalex.org/I1333985979","display_name":"Ministry of Health Labour and Welfare","ror":"https://ror.org/03mwa7s65","country_code":"JP","type":"government","lineage":["https://openalex.org/I1333985979"]},{"id":"https://openalex.org/I205823427","display_name":"Kyowa Kirin (Japan)","ror":"https://ror.org/000wej815","country_code":"JP","type":"company","lineage":["https://openalex.org/I205823427"]},{"id":"https://openalex.org/I60134161","display_name":"Nagoya University","ror":"https://ror.org/04chrp450","country_code":"JP","type":"education","lineage":["https://openalex.org/I60134161"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yuichi Ishikawa","raw_affiliation_strings":["Department of Hematology and Oncology, Nagoya University Graduate School of Medicine","Authorship: TG and MM devised the research and drafted this manuscript. ST, TN, YA, YU, KS, YI, FH, NN, SN, AH, KK, YT, and HK gave advice regarding the study design and data collection. All authors read and approved the final manuscript","Conflict of interest: HK received research funding from Kyowa Hakko Kirin Co., Ltd, Otsuka Pharmaceutical Co., Ltd, FUJIFILM Corporation, Nippon Boehringer Ingelheim Co., Ltd, and Celgene Corporation. These companies are not directly involved in any part of this study. The remaining authors have declared there are no financial conflicts of interest with regard to this study","Ethics and dissemination: The compliance of this study with the Act on the Safety of Regenerative Medicine was confirmed by the Ministry of Health, Labour and Welfare of Japan (number PA8160004). Written informed consent will be obtained from all patients and donors before registration, in accordance with the Declaration of Helsinki. Results of this study will be disseminated via publications in peer-reviewed journals","Trial registration: Trial registration number UMIN000024291"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology and Oncology, Nagoya University Graduate School of Medicine","institution_ids":["https://openalex.org/I60134161"]},{"raw_affiliation_string":"Authorship: TG and MM devised the research and drafted this manuscript. ST, TN, YA, YU, KS, YI, FH, NN, SN, AH, KK, YT, and HK gave advice regarding the study design and data collection. All authors read and approved the final manuscript","institution_ids":[]},{"raw_affiliation_string":"Conflict of interest: HK received research funding from Kyowa Hakko Kirin Co., Ltd, Otsuka Pharmaceutical Co., Ltd, FUJIFILM Corporation, Nippon Boehringer Ingelheim Co., Ltd, and Celgene Corporation. These companies are not directly involved in any part of this study. The remaining authors have declared there are no financial conflicts of interest with regard to this study","institution_ids":["https://openalex.org/I205823427"]},{"raw_affiliation_string":"Ethics and dissemination: The compliance of this study with the Act on the Safety of Regenerative Medicine was confirmed by the Ministry of Health, Labour and Welfare of Japan (number PA8160004). Written informed consent will be obtained from all patients and donors before registration, in accordance with the Declaration of Helsinki. Results of this study will be disseminated via publications in peer-reviewed journals","institution_ids":["https://openalex.org/I1333985979"]},{"raw_affiliation_string":"Trial registration: Trial registration number UMIN000024291","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042332379","display_name":"Fumihiko Hayakawa","orcid":"https://orcid.org/0000-0002-6067-6382","observed_orcids":["https://orcid.org/0000-0002-6067-6382"]},"institutions":[{"id":"https://openalex.org/I1333985979","display_name":"Ministry of Health Labour and Welfare","ror":"https://ror.org/03mwa7s65","country_code":"JP","type":"government","lineage":["https://openalex.org/I1333985979"]},{"id":"https://openalex.org/I205823427","display_name":"Kyowa Kirin (Japan)","ror":"https://ror.org/000wej815","country_code":"JP","type":"company","lineage":["https://openalex.org/I205823427"]},{"id":"https://openalex.org/I60134161","display_name":"Nagoya University","ror":"https://ror.org/04chrp450","country_code":"JP","type":"education","lineage":["https://openalex.org/I60134161"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Fumihiko Hayakawa","raw_affiliation_strings":["Department of Hematology and Oncology, Nagoya University Graduate School of Medicine","Authorship: TG and MM devised the research and drafted this manuscript. ST, TN, YA, YU, KS, YI, FH, NN, SN, AH, KK, YT, and HK gave advice regarding the study design and data collection. All authors read and approved the final manuscript","Conflict of interest: HK received research funding from Kyowa Hakko Kirin Co., Ltd, Otsuka Pharmaceutical Co., Ltd, FUJIFILM Corporation, Nippon Boehringer Ingelheim Co., Ltd, and Celgene Corporation. These companies are not directly involved in any part of this study. The remaining authors have declared there are no financial conflicts of interest with regard to this study","Ethics and dissemination: The compliance of this study with the Act on the Safety of Regenerative Medicine was confirmed by the Ministry of Health, Labour and Welfare of Japan (number PA8160004). Written informed consent will be obtained from all patients and donors before registration, in accordance with the Declaration of Helsinki. Results of this study will be disseminated via publications in peer-reviewed journals","Trial registration: Trial registration number UMIN000024291"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology and Oncology, Nagoya University Graduate School of Medicine","institution_ids":["https://openalex.org/I60134161"]},{"raw_affiliation_string":"Authorship: TG and MM devised the research and drafted this manuscript. ST, TN, YA, YU, KS, YI, FH, NN, SN, AH, KK, YT, and HK gave advice regarding the study design and data collection. All authors read and approved the final manuscript","institution_ids":[]},{"raw_affiliation_string":"Conflict of interest: HK received research funding from Kyowa Hakko Kirin Co., Ltd, Otsuka Pharmaceutical Co., Ltd, FUJIFILM Corporation, Nippon Boehringer Ingelheim Co., Ltd, and Celgene Corporation. These companies are not directly involved in any part of this study. The remaining authors have declared there are no financial conflicts of interest with regard to this study","institution_ids":["https://openalex.org/I205823427"]},{"raw_affiliation_string":"Ethics and dissemination: The compliance of this study with the Act on the Safety of Regenerative Medicine was confirmed by the Ministry of Health, Labour and Welfare of Japan (number PA8160004). Written informed consent will be obtained from all patients and donors before registration, in accordance with the Declaration of Helsinki. Results of this study will be disseminated via publications in peer-reviewed journals","institution_ids":["https://openalex.org/I1333985979"]},{"raw_affiliation_string":"Trial registration: Trial registration number UMIN000024291","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110522852","display_name":"Nobuhiro Nishio","orcid":"https://orcid.org/0000-0002-0267-3853","observed_orcids":["https://orcid.org/0000-0002-0267-3853"]},"institutions":[{"id":"https://openalex.org/I1333985979","display_name":"Ministry of Health Labour and Welfare","ror":"https://ror.org/03mwa7s65","country_code":"JP","type":"government","lineage":["https://openalex.org/I1333985979"]},{"id":"https://openalex.org/I205823427","display_name":"Kyowa Kirin (Japan)","ror":"https://ror.org/000wej815","country_code":"JP","type":"company","lineage":["https://openalex.org/I205823427"]},{"id":"https://openalex.org/I4210090647","display_name":"Nagoya University Hospital","ror":"https://ror.org/008zz8m46","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210090647"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Nobuhiro Nishio","raw_affiliation_strings":["Center for Advanced Medicine and Clinical Research, Nagoya University Hospital","Authorship: TG and MM devised the research and drafted this manuscript. ST, TN, YA, YU, KS, YI, FH, NN, SN, AH, KK, YT, and HK gave advice regarding the study design and data collection. All authors read and approved the final manuscript","Conflict of interest: HK received research funding from Kyowa Hakko Kirin Co., Ltd, Otsuka Pharmaceutical Co., Ltd, FUJIFILM Corporation, Nippon Boehringer Ingelheim Co., Ltd, and Celgene Corporation. These companies are not directly involved in any part of this study. The remaining authors have declared there are no financial conflicts of interest with regard to this study","Ethics and dissemination: The compliance of this study with the Act on the Safety of Regenerative Medicine was confirmed by the Ministry of Health, Labour and Welfare of Japan (number PA8160004). Written informed consent will be obtained from all patients and donors before registration, in accordance with the Declaration of Helsinki. Results of this study will be disseminated via publications in peer-reviewed journals","Trial registration: Trial registration number UMIN000024291"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Advanced Medicine and Clinical Research, Nagoya University Hospital","institution_ids":["https://openalex.org/I4210090647"]},{"raw_affiliation_string":"Authorship: TG and MM devised the research and drafted this manuscript. ST, TN, YA, YU, KS, YI, FH, NN, SN, AH, KK, YT, and HK gave advice regarding the study design and data collection. All authors read and approved the final manuscript","institution_ids":[]},{"raw_affiliation_string":"Conflict of interest: HK received research funding from Kyowa Hakko Kirin Co., Ltd, Otsuka Pharmaceutical Co., Ltd, FUJIFILM Corporation, Nippon Boehringer Ingelheim Co., Ltd, and Celgene Corporation. These companies are not directly involved in any part of this study. The remaining authors have declared there are no financial conflicts of interest with regard to this study","institution_ids":["https://openalex.org/I205823427"]},{"raw_affiliation_string":"Ethics and dissemination: The compliance of this study with the Act on the Safety of Regenerative Medicine was confirmed by the Ministry of Health, Labour and Welfare of Japan (number PA8160004). Written informed consent will be obtained from all patients and donors before registration, in accordance with the Declaration of Helsinki. Results of this study will be disseminated via publications in peer-reviewed journals","institution_ids":["https://openalex.org/I1333985979"]},{"raw_affiliation_string":"Trial registration: Trial registration number UMIN000024291","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075743968","display_name":"Satoshi Nishiwaki","orcid":"https://orcid.org/0000-0002-6430-8958","observed_orcids":["https://orcid.org/0000-0002-6430-8958"]},"institutions":[{"id":"https://openalex.org/I1333985979","display_name":"Ministry of Health Labour and Welfare","ror":"https://ror.org/03mwa7s65","country_code":"JP","type":"government","lineage":["https://openalex.org/I1333985979"]},{"id":"https://openalex.org/I205823427","display_name":"Kyowa Kirin (Japan)","ror":"https://ror.org/000wej815","country_code":"JP","type":"company","lineage":["https://openalex.org/I205823427"]},{"id":"https://openalex.org/I4210090647","display_name":"Nagoya University Hospital","ror":"https://ror.org/008zz8m46","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210090647"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Satoshi Nishiwaki","raw_affiliation_strings":["Center for Advanced Medicine and Clinical Research, Nagoya University Hospital","Authorship: TG and MM devised the research and drafted this manuscript. ST, TN, YA, YU, KS, YI, FH, NN, SN, AH, KK, YT, and HK gave advice regarding the study design and data collection. All authors read and approved the final manuscript","Conflict of interest: HK received research funding from Kyowa Hakko Kirin Co., Ltd, Otsuka Pharmaceutical Co., Ltd, FUJIFILM Corporation, Nippon Boehringer Ingelheim Co., Ltd, and Celgene Corporation. These companies are not directly involved in any part of this study. The remaining authors have declared there are no financial conflicts of interest with regard to this study","Ethics and dissemination: The compliance of this study with the Act on the Safety of Regenerative Medicine was confirmed by the Ministry of Health, Labour and Welfare of Japan (number PA8160004). Written informed consent will be obtained from all patients and donors before registration, in accordance with the Declaration of Helsinki. Results of this study will be disseminated via publications in peer-reviewed journals","Trial registration: Trial registration number UMIN000024291"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Advanced Medicine and Clinical Research, Nagoya University Hospital","institution_ids":["https://openalex.org/I4210090647"]},{"raw_affiliation_string":"Authorship: TG and MM devised the research and drafted this manuscript. ST, TN, YA, YU, KS, YI, FH, NN, SN, AH, KK, YT, and HK gave advice regarding the study design and data collection. All authors read and approved the final manuscript","institution_ids":[]},{"raw_affiliation_string":"Conflict of interest: HK received research funding from Kyowa Hakko Kirin Co., Ltd, Otsuka Pharmaceutical Co., Ltd, FUJIFILM Corporation, Nippon Boehringer Ingelheim Co., Ltd, and Celgene Corporation. These companies are not directly involved in any part of this study. The remaining authors have declared there are no financial conflicts of interest with regard to this study","institution_ids":["https://openalex.org/I205823427"]},{"raw_affiliation_string":"Ethics and dissemination: The compliance of this study with the Act on the Safety of Regenerative Medicine was confirmed by the Ministry of Health, Labour and Welfare of Japan (number PA8160004). Written informed consent will be obtained from all patients and donors before registration, in accordance with the Declaration of Helsinki. Results of this study will be disseminated via publications in peer-reviewed journals","institution_ids":["https://openalex.org/I1333985979"]},{"raw_affiliation_string":"Trial registration: Trial registration number UMIN000024291","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022561314","display_name":"Akihiro Hirakawa","orcid":"https://orcid.org/0000-0003-2580-7460","observed_orcids":["https://orcid.org/0000-0003-2580-7460"]},"institutions":[{"id":"https://openalex.org/I1333985979","display_name":"Ministry of Health Labour and Welfare","ror":"https://ror.org/03mwa7s65","country_code":"JP","type":"government","lineage":["https://openalex.org/I1333985979"]},{"id":"https://openalex.org/I205823427","display_name":"Kyowa Kirin (Japan)","ror":"https://ror.org/000wej815","country_code":"JP","type":"company","lineage":["https://openalex.org/I205823427"]},{"id":"https://openalex.org/I4210090647","display_name":"Nagoya University Hospital","ror":"https://ror.org/008zz8m46","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210090647"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Akihiro Hirakawa","raw_affiliation_strings":["Center for Advanced Medicine and Clinical Research, Nagoya University Hospital","Authorship: TG and MM devised the research and drafted this manuscript. ST, TN, YA, YU, KS, YI, FH, NN, SN, AH, KK, YT, and HK gave advice regarding the study design and data collection. All authors read and approved the final manuscript","Conflict of interest: HK received research funding from Kyowa Hakko Kirin Co., Ltd, Otsuka Pharmaceutical Co., Ltd, FUJIFILM Corporation, Nippon Boehringer Ingelheim Co., Ltd, and Celgene Corporation. These companies are not directly involved in any part of this study. The remaining authors have declared there are no financial conflicts of interest with regard to this study","Ethics and dissemination: The compliance of this study with the Act on the Safety of Regenerative Medicine was confirmed by the Ministry of Health, Labour and Welfare of Japan (number PA8160004). Written informed consent will be obtained from all patients and donors before registration, in accordance with the Declaration of Helsinki. Results of this study will be disseminated via publications in peer-reviewed journals","Trial registration: Trial registration number UMIN000024291"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Advanced Medicine and Clinical Research, Nagoya University Hospital","institution_ids":["https://openalex.org/I4210090647"]},{"raw_affiliation_string":"Authorship: TG and MM devised the research and drafted this manuscript. ST, TN, YA, YU, KS, YI, FH, NN, SN, AH, KK, YT, and HK gave advice regarding the study design and data collection. All authors read and approved the final manuscript","institution_ids":[]},{"raw_affiliation_string":"Conflict of interest: HK received research funding from Kyowa Hakko Kirin Co., Ltd, Otsuka Pharmaceutical Co., Ltd, FUJIFILM Corporation, Nippon Boehringer Ingelheim Co., Ltd, and Celgene Corporation. These companies are not directly involved in any part of this study. The remaining authors have declared there are no financial conflicts of interest with regard to this study","institution_ids":["https://openalex.org/I205823427"]},{"raw_affiliation_string":"Ethics and dissemination: The compliance of this study with the Act on the Safety of Regenerative Medicine was confirmed by the Ministry of Health, Labour and Welfare of Japan (number PA8160004). Written informed consent will be obtained from all patients and donors before registration, in accordance with the Declaration of Helsinki. Results of this study will be disseminated via publications in peer-reviewed journals","institution_ids":["https://openalex.org/I1333985979"]},{"raw_affiliation_string":"Trial registration: Trial registration number UMIN000024291","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110558681","display_name":"Katsuyoshi Kato","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1333985979","display_name":"Ministry of Health Labour and Welfare","ror":"https://ror.org/03mwa7s65","country_code":"JP","type":"government","lineage":["https://openalex.org/I1333985979"]},{"id":"https://openalex.org/I205823427","display_name":"Kyowa Kirin (Japan)","ror":"https://ror.org/000wej815","country_code":"JP","type":"company","lineage":["https://openalex.org/I205823427"]},{"id":"https://openalex.org/I4210090647","display_name":"Nagoya University Hospital","ror":"https://ror.org/008zz8m46","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210090647"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Katsuyoshi Kato","raw_affiliation_strings":["Center for Advanced Medicine and Clinical Research, Nagoya University Hospital","Authorship: TG and MM devised the research and drafted this manuscript. ST, TN, YA, YU, KS, YI, FH, NN, SN, AH, KK, YT, and HK gave advice regarding the study design and data collection. All authors read and approved the final manuscript","Conflict of interest: HK received research funding from Kyowa Hakko Kirin Co., Ltd, Otsuka Pharmaceutical Co., Ltd, FUJIFILM Corporation, Nippon Boehringer Ingelheim Co., Ltd, and Celgene Corporation. These companies are not directly involved in any part of this study. The remaining authors have declared there are no financial conflicts of interest with regard to this study","Ethics and dissemination: The compliance of this study with the Act on the Safety of Regenerative Medicine was confirmed by the Ministry of Health, Labour and Welfare of Japan (number PA8160004). Written informed consent will be obtained from all patients and donors before registration, in accordance with the Declaration of Helsinki. Results of this study will be disseminated via publications in peer-reviewed journals","Trial registration: Trial registration number UMIN000024291"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Advanced Medicine and Clinical Research, Nagoya University Hospital","institution_ids":["https://openalex.org/I4210090647"]},{"raw_affiliation_string":"Authorship: TG and MM devised the research and drafted this manuscript. ST, TN, YA, YU, KS, YI, FH, NN, SN, AH, KK, YT, and HK gave advice regarding the study design and data collection. All authors read and approved the final manuscript","institution_ids":[]},{"raw_affiliation_string":"Conflict of interest: HK received research funding from Kyowa Hakko Kirin Co., Ltd, Otsuka Pharmaceutical Co., Ltd, FUJIFILM Corporation, Nippon Boehringer Ingelheim Co., Ltd, and Celgene Corporation. These companies are not directly involved in any part of this study. The remaining authors have declared there are no financial conflicts of interest with regard to this study","institution_ids":["https://openalex.org/I205823427"]},{"raw_affiliation_string":"Ethics and dissemination: The compliance of this study with the Act on the Safety of Regenerative Medicine was confirmed by the Ministry of Health, Labour and Welfare of Japan (number PA8160004). Written informed consent will be obtained from all patients and donors before registration, in accordance with the Declaration of Helsinki. Results of this study will be disseminated via publications in peer-reviewed journals","institution_ids":["https://openalex.org/I1333985979"]},{"raw_affiliation_string":"Trial registration: Trial registration number UMIN000024291","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102784952","display_name":"Yoshiyuki Takahashi","orcid":"https://orcid.org/0000-0001-8644-171X","observed_orcids":["https://orcid.org/0000-0001-8644-171X"]},"institutions":[{"id":"https://openalex.org/I1333985979","display_name":"Ministry of Health Labour and Welfare","ror":"https://ror.org/03mwa7s65","country_code":"JP","type":"government","lineage":["https://openalex.org/I1333985979"]},{"id":"https://openalex.org/I205823427","display_name":"Kyowa Kirin (Japan)","ror":"https://ror.org/000wej815","country_code":"JP","type":"company","lineage":["https://openalex.org/I205823427"]},{"id":"https://openalex.org/I60134161","display_name":"Nagoya University","ror":"https://ror.org/04chrp450","country_code":"JP","type":"education","lineage":["https://openalex.org/I60134161"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yoshiyuki Takahashi","raw_affiliation_strings":["Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan","Authorship: TG and MM devised the research and drafted this manuscript. ST, TN, YA, YU, KS, YI, FH, NN, SN, AH, KK, YT, and HK gave advice regarding the study design and data collection. All authors read and approved the final manuscript","Conflict of interest: HK received research funding from Kyowa Hakko Kirin Co., Ltd, Otsuka Pharmaceutical Co., Ltd, FUJIFILM Corporation, Nippon Boehringer Ingelheim Co., Ltd, and Celgene Corporation. These companies are not directly involved in any part of this study. The remaining authors have declared there are no financial conflicts of interest with regard to this study","Ethics and dissemination: The compliance of this study with the Act on the Safety of Regenerative Medicine was confirmed by the Ministry of Health, Labour and Welfare of Japan (number PA8160004). Written informed consent will be obtained from all patients and donors before registration, in accordance with the Declaration of Helsinki. Results of this study will be disseminated via publications in peer-reviewed journals","Trial registration: Trial registration number UMIN000024291"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan","institution_ids":["https://openalex.org/I60134161"]},{"raw_affiliation_string":"Authorship: TG and MM devised the research and drafted this manuscript. ST, TN, YA, YU, KS, YI, FH, NN, SN, AH, KK, YT, and HK gave advice regarding the study design and data collection. All authors read and approved the final manuscript","institution_ids":[]},{"raw_affiliation_string":"Conflict of interest: HK received research funding from Kyowa Hakko Kirin Co., Ltd, Otsuka Pharmaceutical Co., Ltd, FUJIFILM Corporation, Nippon Boehringer Ingelheim Co., Ltd, and Celgene Corporation. These companies are not directly involved in any part of this study. The remaining authors have declared there are no financial conflicts of interest with regard to this study","institution_ids":["https://openalex.org/I205823427"]},{"raw_affiliation_string":"Ethics and dissemination: The compliance of this study with the Act on the Safety of Regenerative Medicine was confirmed by the Ministry of Health, Labour and Welfare of Japan (number PA8160004). Written informed consent will be obtained from all patients and donors before registration, in accordance with the Declaration of Helsinki. Results of this study will be disseminated via publications in peer-reviewed journals","institution_ids":["https://openalex.org/I1333985979"]},{"raw_affiliation_string":"Trial registration: Trial registration number UMIN000024291","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5002642944","display_name":"Hitoshi Kiyoi","orcid":"https://orcid.org/0000-0001-6382-9498","observed_orcids":["https://orcid.org/0000-0001-6382-9498"]},"institutions":[{"id":"https://openalex.org/I1333985979","display_name":"Ministry of Health Labour and Welfare","ror":"https://ror.org/03mwa7s65","country_code":"JP","type":"government","lineage":["https://openalex.org/I1333985979"]},{"id":"https://openalex.org/I205823427","display_name":"Kyowa Kirin (Japan)","ror":"https://ror.org/000wej815","country_code":"JP","type":"company","lineage":["https://openalex.org/I205823427"]},{"id":"https://openalex.org/I60134161","display_name":"Nagoya University","ror":"https://ror.org/04chrp450","country_code":"JP","type":"education","lineage":["https://openalex.org/I60134161"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hitoshi Kiyoi","raw_affiliation_strings":["Department of Hematology and Oncology, Nagoya University Graduate School of Medicine","Authorship: TG and MM devised the research and drafted this manuscript. ST, TN, YA, YU, KS, YI, FH, NN, SN, AH, KK, YT, and HK gave advice regarding the study design and data collection. All authors read and approved the final manuscript","Conflict of interest: HK received research funding from Kyowa Hakko Kirin Co., Ltd, Otsuka Pharmaceutical Co., Ltd, FUJIFILM Corporation, Nippon Boehringer Ingelheim Co., Ltd, and Celgene Corporation. These companies are not directly involved in any part of this study. The remaining authors have declared there are no financial conflicts of interest with regard to this study","Ethics and dissemination: The compliance of this study with the Act on the Safety of Regenerative Medicine was confirmed by the Ministry of Health, Labour and Welfare of Japan (number PA8160004). Written informed consent will be obtained from all patients and donors before registration, in accordance with the Declaration of Helsinki. Results of this study will be disseminated via publications in peer-reviewed journals","Trial registration: Trial registration number UMIN000024291"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology and Oncology, Nagoya University Graduate School of Medicine","institution_ids":["https://openalex.org/I60134161"]},{"raw_affiliation_string":"Authorship: TG and MM devised the research and drafted this manuscript. ST, TN, YA, YU, KS, YI, FH, NN, SN, AH, KK, YT, and HK gave advice regarding the study design and data collection. All authors read and approved the final manuscript","institution_ids":[]},{"raw_affiliation_string":"Conflict of interest: HK received research funding from Kyowa Hakko Kirin Co., Ltd, Otsuka Pharmaceutical Co., Ltd, FUJIFILM Corporation, Nippon Boehringer Ingelheim Co., Ltd, and Celgene Corporation. These companies are not directly involved in any part of this study. The remaining authors have declared there are no financial conflicts of interest with regard to this study","institution_ids":["https://openalex.org/I205823427"]},{"raw_affiliation_string":"Ethics and dissemination: The compliance of this study with the Act on the Safety of Regenerative Medicine was confirmed by the Ministry of Health, Labour and Welfare of Japan (number PA8160004). Written informed consent will be obtained from all patients and donors before registration, in accordance with the Declaration of Helsinki. Results of this study will be disseminated via publications in peer-reviewed journals","institution_ids":["https://openalex.org/I1333985979"]},{"raw_affiliation_string":"Trial registration: Trial registration number UMIN000024291","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5022043062"],"corresponding_institution_ids":["https://openalex.org/I60134161"],"apc_list":{"value":1950,"currency":"USD","value_usd":1950},"apc_paid":{"value":1950,"currency":"USD","value_usd":1950},"fwci":4.3005,"has_fulltext":false,"cited_by_count":30,"citation_normalized_percentile":{"value":0.94844781,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":100},"biblio":{"volume":"97","issue":"17","first_page":"e0449","last_page":"e0449"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10176","display_name":"Mesenchymal stem cell research","score":0.00139999995008111,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11189","display_name":"Transplantation: Methods and Outcomes","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cord-blood-transplantation","display_name":"cord blood transplantation","score":0.9890000224113464},{"id":"https://openalex.org/keywords/mesenchymal-stem-cells","display_name":"mesenchymal stem cells","score":0.996999979019165},{"id":"https://openalex.org/keywords/graft-versus-host-disease-prophylaxis","display_name":"graft-versus-host disease prophylaxis","score":0.7590000033378601},{"id":"https://openalex.org/keywords/hematopoietic-engraftment","display_name":"hematopoietic engraftment","score":0.8399999737739563},{"id":"https://openalex.org/keywords/allogeneic-hematopoietic-stem-cell-transplantation","display_name":"allogeneic hematopoietic stem cell transplantation","score":0.8740000128746033},{"id":"https://openalex.org/keywords/third-party-donor","display_name":"third-party donor","score":0.5830000042915344},{"id":"https://openalex.org/keywords/tacrolimus","display_name":"tacrolimus","score":0.6899999976158142},{"id":"https://openalex.org/keywords/methotrexate","display_name":"methotrexate","score":0.9509999752044678},{"id":"https://openalex.org/keywords/hematologic-disorders","display_name":"hematologic disorders","score":0.7089999914169312},{"id":"https://openalex.org/keywords/adult-patients","display_name":"adult patients","score":0.7179999947547913}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9789122939109802},{"id":"https://openalex.org/C198826908","wikidata":"https://www.wikidata.org/wiki/Q1922379","display_name":"Mesenchymal stem cell","level":2,"score":0.6670716404914856},{"id":"https://openalex.org/C2780914630","wikidata":"https://www.wikidata.org/wiki/Q914952","display_name":"Cord blood","level":2,"score":0.5771516561508179},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.45762714743614197},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.2666305899620056},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.26612794399261475},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.22525963187217712}],"mesh":[{"descriptor_ui":"D001853","descriptor_name":"Bone Marrow","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017321","descriptor_name":"Clinical Trials, Phase I as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019172","descriptor_name":"Transplantation Conditioning","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D036101","descriptor_name":"Cord Blood Stem Cell Transplantation","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D045164","descriptor_name":"Mesenchymal Stem Cell Transplantation","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1097/md.0000000000010449","doi":"https://doi.org/10.1097/md.0000000000010449","is_oa":true,"landing_page_url":"https://doi.org/10.1097/md.0000000000010449","pdf_url":null,"source":{"id":"https://openalex.org/S28966261","display_name":"Medicine","issn_l":"0025-7974","issn":["0025-7974","1536-5964"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Medicine","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:4871066","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5944542","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:5944542","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5944542","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Medicine (Baltimore)","raw_type":"Text"},{"id":"pmid:29702996","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29702996","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Medicine","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1097/md.0000000000010449","doi":"https://doi.org/10.1097/md.0000000000010449","is_oa":true,"landing_page_url":"https://doi.org/10.1097/md.0000000000010449","pdf_url":null,"source":{"id":"https://openalex.org/S28966261","display_name":"Medicine","issn_l":"0025-7974","issn":["0025-7974","1536-5964"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Medicine","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/study-protocol","display_name":"Study Protocol"}],"awards":[{"id":"https://openalex.org/G1044856160","display_name":null,"funder_award_id":"17ek0510022h0001","funder_id":"https://openalex.org/F4320311405","funder_display_name":"Japan Agency for Medical Research and Development"},{"id":"https://openalex.org/G4003445724","display_name":"Significance of BCR gene breakpoint in Ph + ALL","funder_award_id":"17K16186","funder_id":"https://openalex.org/F4320334764","funder_display_name":"Japan Society for the Promotion of Science"},{"id":"https://openalex.org/G740530335","display_name":"Enhancement of Intracellular Signaling in T Cell Receptor-transduced T Cells","funder_award_id":"18K08351","funder_id":"https://openalex.org/F4320334764","funder_display_name":"Japan Society for the Promotion of Science"}],"funders":[{"id":"https://openalex.org/F4320311405","display_name":"Japan Agency for Medical Research and Development","ror":"https://ror.org/004rtk039"},{"id":"https://openalex.org/F4320334764","display_name":"Japan Society for the Promotion of Science","ror":"https://ror.org/00hhkn466"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":30,"referenced_works":["https://openalex.org/W1491993932","https://openalex.org/W1530764705","https://openalex.org/W1966039996","https://openalex.org/W1972617018","https://openalex.org/W1978876757","https://openalex.org/W1979043688","https://openalex.org/W2008028335","https://openalex.org/W2025013227","https://openalex.org/W2028860972","https://openalex.org/W2037736150","https://openalex.org/W2038399651","https://openalex.org/W2038413306","https://openalex.org/W2041864288","https://openalex.org/W2050996699","https://openalex.org/W2064462932","https://openalex.org/W2073595786","https://openalex.org/W2088500471","https://openalex.org/W2109108598","https://openalex.org/W2112254862","https://openalex.org/W2139708930","https://openalex.org/W2149176302","https://openalex.org/W2160434297","https://openalex.org/W2168717833","https://openalex.org/W2174299838","https://openalex.org/W2189304488","https://openalex.org/W2190125394","https://openalex.org/W2289084597","https://openalex.org/W2379365975","https://openalex.org/W2618073389","https://openalex.org/W2624097304"],"related_works":["https://openalex.org/W3112234538","https://openalex.org/W4368376494","https://openalex.org/W2769203914","https://openalex.org/W2045494596","https://openalex.org/W2401320106","https://openalex.org/W2483390952","https://openalex.org/W2050996699","https://openalex.org/W2346259140","https://openalex.org/W2024249413","https://openalex.org/W2739582453"],"abstract_inverted_index":{"INTRODUCTION:":[0],"Delayed":[1],"hematological":[2,190],"recovery,":[3],"graft":[4,100],"failure,":[5],"and":[6,31,39,57,75,148,203,259,269],"acute":[7,47],"graft-versus-host":[8],"disease":[9],"(GVHD)":[10],"still":[11],"remain":[12],"major":[13],"problems":[14],"in":[15,86,91],"cord":[16,83,123,248],"blood":[17,84,124,249],"transplantation":[18,64],"(CBT).":[19],"Mesenchymal":[20],"stem":[21],"cells":[22,85,125],"(MSCs)":[23],"are":[24,40,95,192,231],"known":[25],"to":[26,54,118,140,145,164,256],"support":[27],"bone":[28,181],"marrow":[29,112,173,182,236],"stroma":[30],"promote":[32],"hematopoiesis.":[33],"Additionally,":[34],"MSCs":[35,53,81,115,179,214,230,281],"possess":[36],"immunomodulatory":[37],"properties":[38],"used":[41],"clinically":[42],"for":[43,103,194],"the":[44,50,73,104,120,166,204,226,234,238,243],"treatment":[45],"of":[46,52,77,80,99,106,108,114,122,168,175,183,213,221,228,237,245,264,267,274,280],"GVHD.":[48],"Therefore,":[49],"use":[51],"enhance":[55,119,146],"engraftment":[56,121,147],"prevent":[58,149],"GVHD":[59,150,261],"after":[60,151,285],"allogeneic":[61],"hematopoietic":[62],"cell":[63],"has":[65],"been":[66],"explored.":[67],"Recent":[68],"clinical":[69,136,162],"trials":[70],"have":[71],"shown":[72],"feasibility":[74],"safety":[76,167],"intravenous":[78,128],"cotransplantation":[79],"with":[82,171,189],"pediatric":[87],"patients,":[88,93],"but":[89],"not":[90],"adult":[92],"who":[94],"at":[96],"greater":[97],"risk":[98],"failure.":[101],"As":[102],"route":[105],"administration":[107],"MSCs,":[109],"direct":[110],"intrabone":[111,172,235],"injection":[113,174],"is":[116,157,201,207,216,277],"thought":[117],"more":[126],"than":[127],"injection.":[129],"Based":[130],"on":[131],"these":[132],"background":[133],"findings,":[134],"this":[135,195,275],"trial":[137],"was":[138],"designed":[139],"develop":[141],"a":[142,158,184,246,265],"new":[143],"strategy":[144],"CBT.":[152],"METHODS":[153],"AND":[154],"ANALYSIS:":[155],"This":[156],"single-center,":[159],"phase":[160],"I,":[161],"study":[163,276],"evaluate":[165],"CBT":[169],"combined":[170],"ex":[176],"vivo":[177],"expanded":[178],"from":[180],"third-party":[185],"donor.":[186],"Adult":[187],"patients":[188],"disorders":[191],"eligible":[193],"study.":[196],"The":[197,210,251,271],"target":[198,211],"sample":[199],"size":[200],"5,":[202],"registration":[205],"period":[206],"3":[208],"years.":[209],"dose":[212],"infused":[215],"0.5":[217],"\u00d7":[218],"10":[219],"cells/kg":[220],"patient":[222,239,257],"body":[223],"weight.":[224],"On":[225],"day":[227],"CBT,":[229],"injected":[232],"into":[233],"4":[240],"hours":[241],"before":[242],"infusion":[244],"single":[247],"unit.":[250],"conditioning":[252],"regimen":[253],"varies":[254],"according":[255],"age":[258],"disease.":[260],"prophylaxis":[262],"consists":[263],"combination":[266],"tacrolimus":[268],"methotrexate.":[270],"primary":[272],"endpoint":[273],"infusional":[278],"toxicity":[279],"within":[282],"14":[283],"days":[284],"transplantation.":[286]},"counts_by_year":[{"year":2024,"cited_by_count":2},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":18},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2018-05-17T00:00:00"}